Zenotech Laboratories

Zenotech Laboratories Days Payable Outstanding

The Days Payable Outstanding (DPO) of Zenotech Laboratories (532039.BO) as of Nov 22, 2026 is 201.67. In the previous year, Days Payable Outstanding (DPO) was 115.47 — a change of 74.65% (higher).

Days Payable Outstanding

201.67

YoY

74.65%

Last updated:

Days Payable Outstanding (DPO) of Zenotech Laboratories is 2026 201.67 . Days Payable Outstanding (DPO) of Zenotech Laboratories was 2025 115.47 . It decreases by 74.65% higher compared to the previous year.

The Zenotech Laboratories Days Payable Outstanding history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Days Payable Outstanding
Date
Days Payable Outstanding
Jan 1, 2019
649.69 INR
Jan 1, 2020
698.91 INR
Jan 1, 2021
295.08 INR
Jan 1, 2022
295.31 INR
Jan 1, 2023
172.28 INR
Jan 1, 2024
148.53 INR
Jan 1, 2025
115.47 INR
Jan 1, 2026
201.67 INR
The Zenotech Laboratories Days Payable Outstanding history
YEARDays Payable OutstandingYoY
201.67+74.65%
115.47-22.26%
148.53-13.79%
172.28-41.66%
295.31+0.08%
295.08-57.78%
698.91+7.58%
649.69-21.58%
828.47-26.22%
1,122.95+47.12%
763.27+502.52%
126.68-12.41%
144.63—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Zenotech Laboratories Stock analysis

What does Zenotech Laboratories do? Zenotech Laboratories Ltd manufactures and markets pharmaceutical products, specializing in oncology, biotechnology, and general injectables. The company operates from a manufacturing facility in Turkapally village, Shamirpet Mandal, Telangana, producing specialty generic injectables for the pharmaceutical sector. Its products are sold to healthcare providers and distributors within the pharmaceutical industry, targeting markets that require specialized injectable solutions. The firm's business model focuses on the production and distribution of generic injectables, leveraging its facility in Telangana to serve both domestic and international markets. By concentrating on oncology and biotechnology injectables, Zenotech addresses specific medical needs, generating revenue through the sale of these high-demand pharmaceutical products to hospitals, clinics, and pharmaceutical distributors. Zenotech Laboratories Ltd's revenue streams come from the sale of its specialty generic injectables, including oncology and biotechnology products, to healthcare institutions and distribution networks. The company's manufacturing capabilities in Telangana support its role as a supplier in the pharmaceutical supply chain, with a focus on injectable formulations that cater to critical healthcare applications. Zenotech Laboratories is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Zenotech Laboratories stock

Days Payable Outstanding (DPO) of Zenotech Laboratories is 201.67 in 2026.

Days Payable Outstanding (DPO) of Zenotech Laboratories changed from 115.47 to 201.67, representing a 74.65% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Days Payable Outstanding (DPO) Zenotech Laboratories since 2006 – with annual values, charts, and detailed analysis.

DPO measures the average number of days a company takes to pay its suppliers. Higher DPO can improve cash flow but may strain supplier relationships.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Days Payable Outstanding (DPO)'s Zenotech Laboratories with sector peers and the industry average to assess whether it is attractive.

To evaluate Days Payable Outstanding (DPO)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Days Payable Outstanding (DPO).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Zenotech Laboratories

All Key Metrics — Zenotech Laboratories